Ajanta Pharma logo

Ajanta Pharma shareholders and shareholding pattern

NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap

Last close ₹3,283.90up ₹13.30 (0.41%)BSE ₹3,281.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹3,270.60.

52-week range of traded prices to 23 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
Market cap
₹41,035 Cr236th largest listed
P/E
36.2
P/B
9.1
Dividend yield
1.83%
ROE
27.3%
ROCE
27.2%
Debt to equity
0.05
Volume, NSE
1,54,84762.5% delivered

Who owns Ajanta Pharma, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters63.47%
  • Foreign institutions7.63%
  • Indian institutions21.94%
  • GovernmentsNone
  • Individuals and others6.96%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Foreign institutions
  • Indian institutions
  • Governments
  • Individuals and others
Per centDec 2016Filed 10 JanMar 2017Filed 10 AprJun 2017Filed 14 JulSep 2017Filed 2 NovDec 2017Filed 18 JanMar 2018Filed 17 AprJun 2018Filed 12 JulSep 2018Filed 6 OctDec 2018Filed 14 JanMar 2019Filed 9 AprJun 2019Filed 10 JulSep 2019Filed 15 OctDec 2019Filed 7 JanMar 2020Filed 7 AprJun 2020Filed 9 JulSep 2020Filed 13 OctDec 2020Filed 11 JanMar 2021Filed 8 AprJun 2021Filed 8 JulSep 2021Filed 14 OctDec 2021Filed 12 JanMar 2022Filed 12 AprJun 2022Filed 14 JulSep 2022Filed 10 OctDec 2022Filed 16 JanMar 2023Filed 12 AprJun 2023Filed 7 JulSep 2023Filed 10 OctDec 2023Filed 12 JanMar 2024Filed 12 AprJun 2024Filed 12 JulSep 2024Filed 10 OctDec 2024Filed 7 JanMar 2025Filed 9 AprJun 2025Filed 17 JulSep 2025Filed 14 OctDec 2025Filed 12 JanMar 2026Filed 13 AprJun 2026Filed 14 JulSep 2026Filed 13 Oct
73.78%73.78%73.78%70.70%70.70%70.70%70.48%70.47%70.47%70.52%70.52%70.51%70.51%70.51%70.51%70.51%70.34%70.34%70.34%70.34%70.34%70.48%70.48%70.48%66.11%66.11%66.21%66.21%66.21%66.21%66.27%66.26%66.26%66.26%66.26%66.25%66.25%66.25%63.48%63.47%
Indian promoters73.78%73.78%73.78%70.70%70.70%70.70%70.48%70.47%70.47%70.52%70.52%70.51%70.51%70.51%70.51%70.51%70.34%70.34%70.34%70.34%70.34%70.48%70.48%70.48%66.11%66.11%66.21%66.21%66.21%66.21%66.27%66.26%66.26%66.26%66.26%66.25%66.25%66.25%63.48%63.47%
26.22%26.22%26.22%29.30%29.30%29.30%29.52%29.53%29.53%29.48%29.48%29.49%29.49%29.49%29.49%29.49%29.66%29.66%29.66%29.66%29.66%29.52%29.52%29.52%33.89%33.89%33.79%33.79%33.79%33.79%33.73%33.74%33.74%33.74%33.74%33.75%33.75%33.75%36.52%36.53%
Promoter shares pledgedShare of the promoters' own shares6.92%9.66%11.00%10.06%10.06%10.27%11.21%11.70%12.85%15.83%13.37%17.77%16.86%17.29%16.15%16.06%15.17%15.49%14.95%13.73%15.37%16.60%20.09%17.42%19.87%11.41%13.23%12.43%12.33%12.26%11.57%11.17%11.17%12.61%14.12%15.28%17.29%17.94%22.53%20.65%
Shares in issue8,80,05,0008,80,05,0008,80,06,0008,80,14,5008,80,14,5008,80,14,5008,80,15,5008,80,23,0008,80,23,0008,72,53,7708,72,54,7708,72,61,2708,72,61,2708,72,61,2708,72,61,2708,72,61,2708,65,31,7708,65,31,7708,65,31,7708,65,35,7708,65,35,7708,54,15,77012,81,25,15512,81,25,15512,81,25,15512,81,25,15512,59,15,65512,59,15,65512,59,15,65512,59,15,65512,48,87,77412,49,12,09912,49,12,09912,49,12,09912,49,12,09912,49,35,62412,49,35,62412,49,35,62412,49,35,62412,49,59,024
Shares locked in3,7503,7501,0009,5009,5009,5009,5008,5008,5008,5008,5007,5007,5007,5006,500–5,5005,5005,5009,5004,0004,0007,5001,5001,5001,5001,0001,0001,0001,0001,00025,32525,32525,32524,32523,52523,52523,52523,52523,400
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Ajanta Pharma shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersDec 2016Filed 10 JanMar 2017Filed 10 AprJun 2017Filed 14 JulSep 2017Filed 2 NovDec 2017Filed 18 JanMar 2018Filed 17 AprJun 2018Filed 12 JulSep 2018Filed 6 OctDec 2018Filed 14 JanMar 2019Filed 9 AprJun 2019Filed 10 JulSep 2019Filed 15 OctDec 2019Filed 7 JanMar 2020Filed 7 AprJun 2020Filed 9 JulSep 2020Filed 13 OctDec 2020Filed 11 JanMar 2021Filed 8 AprJun 2021Filed 8 JulSep 2021Filed 14 OctDec 2021Filed 12 JanMar 2022Filed 12 AprJun 2022Filed 14 JulSep 2022Filed 10 OctDec 2022Filed 16 JanMar 2023Filed 12 AprJun 2023Filed 7 JulSep 2023Filed 10 OctDec 2023Filed 12 JanMar 2024Filed 12 AprJun 2024Filed 12 JulSep 2024Filed 10 OctDec 2024Filed 7 JanMar 2025Filed 9 AprJun 2025Filed 17 JulSep 2025Filed 14 OctDec 2025Filed 12 JanMar 2026Filed 13 AprJun 2026Filed 14 JulSep 2026Filed 13 Oct
All shareholders34,99138,06935,07240,92635,23035,39439,06137,30237,18739,91238,02236,15535,74239,18846,34448,84349,45944,88145,67252,26357,89760,75964,44562,04859,79883,54954,87456,27754,35155,48870,31664,31566,89670,82768,88267,78565,40967,95565,29661,923
910101010119999999999888888888888888888888888
Indian promoters910101010119999999999888888888888888888888888
34,98238,05935,06240,91635,22035,38339,05237,29337,17839,90338,01336,14635,73339,17946,33548,83449,45144,87345,66452,25557,88960,75164,43762,04059,79083,54154,86656,26954,34355,48070,30864,30766,88870,81968,87467,77765,40167,94765,28861,915
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Ajanta Pharma promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Yogesh M Agrawal, trustee Yogesh Agrawal Trust, 14.47%. The filing names 1 more member with no shares.Promoter buying and selling

Holder
Yogesh M Agrawal, trustee Yogesh Agrawal TrustIndividuals and Hindu undivided families14.47%1,80,78,1470.00%
Rajesh M Agrawal, trustee Rajesh Agrawal TrustIndividuals and Hindu undivided families14.47%1,80,78,1480.00%
Aayush M Agrawal, trustee Aayush Agrawal TrustIndividuals and Hindu undivided families11.29%1,41,12,92485.75%
Ravi P Agrawal, trustee Ravi Agrawal TrustIndividuals and Hindu undivided families10.24%1,27,92,90411.52%
Gabs Investments Pvt LtdIndian companies, trusts and others10.07%1,25,88,39322.00%
Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi AgrawalIndividuals and Hindu undivided families2.68%33,48,2610.00%
Ravi P AgrawalIndividuals and Hindu undivided families0.23%2,85,0000.00%
Aayush M AgrawalIndividuals and Hindu undivided families0.02%30,000100.00%
Pledged is the share of the holder's own shares pledged to a lender.

Largest public holders of Ajanta Pharma, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Ajanta Pharma

HolderDec 2016Filed 10 JanMar 2017Filed 10 AprJun 2017Filed 14 JulSep 2017Filed 2 NovDec 2017Filed 18 JanMar 2018Filed 17 AprJun 2018Filed 12 JulSep 2018Filed 6 OctDec 2018Filed 14 JanMar 2019Filed 9 AprJun 2019Filed 10 JulSep 2019Filed 15 OctDec 2019Filed 7 JanMar 2020Filed 7 AprJun 2020Filed 9 JulSep 2020Filed 13 OctDec 2020Filed 11 JanMar 2021Filed 8 AprJun 2021Filed 8 JulSep 2021Filed 14 OctDec 2021Filed 12 JanMar 2022Filed 12 AprJun 2022Filed 14 JulSep 2022Filed 10 OctDec 2022Filed 16 JanMar 2023Filed 12 AprJun 2023Filed 7 JulSep 2023Filed 10 OctDec 2023Filed 12 JanMar 2024Filed 12 AprJun 2024Filed 12 JulSep 2024Filed 10 OctDec 2024Filed 7 JanMar 2025Filed 9 AprJun 2025Filed 17 JulSep 2025Filed 14 OctDec 2025Filed 12 JanMar 2026Filed 13 AprJun 2026Filed 14 JulSep 2026Filed 13 Oct
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110Insurance companies–––––––––––––––––––––––––1.21%1.51%1.64%1.64%1.65%1.67%1.34%1.24%1.25%1.45%1.85%1.81%1.77%1.90%1.91%
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity FundInsurance companies––––––––––––––––––––––––1.17%–––––––––––––––
Mattews India FundInstitutions Foreign Portfolio Investor––––––3.40%3.42%–2.38%2.07%–––––––––––––––––––––––––––––
Kotak Mahindra (International) LimitedInstitutions Foreign Portfolio Investor1.10%1.10%1.10%1.10%1.10%1.10%1.10%1.10%1.10%1.11%––––––––––––––––––––––––––––––
Matthews India FundInstitutions Foreign Portfolio Investor2.53%2.53%2.76%3.33%3.40%3.40%––3.58%–––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.